Risperidone 0.5 mg, 1 mg, 2 mg, and 3 mg tablets: Supply issue
There is a supply issue affecting Risperidone (Teva) tablets.
20 November 2024
Affected product
There are supply issues affecting the follow presentations:
| Chemical | Brand | Presentation | Pharmacode | Subsidy | Measure/Qty |
|---|---|---|---|---|---|
| Risperidone | Risperidone (Teva) | Tab 0.5 mg | 2466899 | $2.17 | per 60 |
| Risperidone | Risperidone (Teva) | Tab 1 mg | 2466902 | $2.44 | per 60 |
| Risperidone | Risperidone (Teva) | Tab 2 mg | 2466910 | $2.72 | per 60 |
| Risperidone | Risperidone (Teva) | Tab 3 mg | 2466929 | $4.50 | per 60 |
Schedule listing: Risperidone(external link)
Supply status
| Risperidone Teva | Risperdal | Risperidone Sandoz (S29) | |
| 0.5 mg | Stock available More supply expected November |
Out of stock | Stock available |
| 1 mg | Out of stock Resupply expected late December |
Out of stock | Stock available |
| 2 mg | Out of stock Stock expected early December |
Out of stock | Stock available |
| 3 mg | Out of stock Resupply expected December |
Out of stock | Stock available |
| 4 mg | Stock available More supply expected November |
Out of stock | N/A |
The oral liquid and depot injections are unaffected by this supply issue.
Alternatives
Risperidone Sandoz
From 4 October 2024. Risperidone Sandoz will be listed in the Community Schedule (1 November for the HML). It will not appear in the Online Schedule until it is updated for 1 November. It is not Medsafe registered and will need to be prescribed and dispensed in line with section 29 of the Medicines Act.
| Chemical and presentation (60 pack) |
Price | Pharmacode |
|---|---|---|
| Risperidone tab 0.5 mg | $4.01 | 2693143 |
| Risperidone tab 1 mg | $3.68 | 2693151 |
| Risperidone tab 2 mg | $5.38 | 2693178 |
| Risperidone tab 3 mg | $8.57 | 2693186 |
- Risperidone Supply issue (Oct 24) A5 flier [PDF 197 KB]
Risperdal
Risperdal tablets have been listed, however there is limited availability of some strengths. People may also need to take multiple tablets to make up their dose.
We have created fliers to support pharmacists' conversations with people about the brand changes and changes to the number of tablets.
Medsafe datasheet for Risperdal(external link)
The oral liquid is also available in significant quantities. However people would need a new prescription.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)